<!DOCTYPE html>
<html lang="zh-CN">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="chapt 11.10 å°è‚½  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š è‚½ç±»æ¿€ç´  (Peptide hormones, N): ä¸€ç±»ç”± 5-60 ä¸ªæ°¨åŸºé…¸æ®‹åŸºç»„æˆçš„å°åˆ†å­ä¿¡å·å¤šè‚½ã€‚å®ƒä»¬ä½œä¸ºå—ä½“é…ä½“ï¼ˆLigandï¼‰ï¼Œåœ¨æä½æµ“åº¦ä¸‹ï¼ˆå¦‚é£æ‘©å°”çº§åˆ« femtomolarï¼‰å³å¯è°ƒèŠ‚æ¤ç‰©çš„ç”Ÿé•¿ã€å‘è‚²åŠé€†å¢ƒå“åº”ã€‚ä¾‹å¦‚ç³»ç»Ÿç´ ï¼ˆSyst...">
    <meta name="keywords" content="æ¤ç‰©ç”Ÿç†å­¦/ååŠ, chapt 11.10 å°è‚½">
    <meta name="author" content="Yukari502">
    <meta name="article-slug" content="chapt-1110-å°è‚½">
    <meta name="root-path" content="../../">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-1110-å°è‚½.html">
    <meta property="og:title" content="chapt 11.10 å°è‚½">
    <meta property="og:description" content="chapt 11.10 å°è‚½  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š è‚½ç±»æ¿€ç´  (Peptide hormones, N): ä¸€ç±»ç”± 5-60 ä¸ªæ°¨åŸºé…¸æ®‹åŸºç»„æˆçš„å°åˆ†å­ä¿¡å·å¤šè‚½ã€‚å®ƒä»¬ä½œä¸ºå—ä½“é…ä½“ï¼ˆLigandï¼‰ï¼Œåœ¨æä½æµ“åº¦ä¸‹ï¼ˆå¦‚é£æ‘©å°”çº§åˆ« femtomolarï¼‰å³å¯è°ƒèŠ‚æ¤ç‰©çš„ç”Ÿé•¿ã€å‘è‚²åŠé€†å¢ƒå“åº”ã€‚ä¾‹å¦‚ç³»ç»Ÿç´ ï¼ˆSyst...">
    <meta property="og:site_name" content="Digital Garden">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-1110-å°è‚½.html">
    <meta property="twitter:title" content="chapt 11.10 å°è‚½">
    <meta property="twitter:description" content="chapt 11.10 å°è‚½  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š è‚½ç±»æ¿€ç´  (Peptide hormones, N): ä¸€ç±»ç”± 5-60 ä¸ªæ°¨åŸºé…¸æ®‹åŸºç»„æˆçš„å°åˆ†å­ä¿¡å·å¤šè‚½ã€‚å®ƒä»¬ä½œä¸ºå—ä½“é…ä½“ï¼ˆLigandï¼‰ï¼Œåœ¨æä½æµ“åº¦ä¸‹ï¼ˆå¦‚é£æ‘©å°”çº§åˆ« femtomolarï¼‰å³å¯è°ƒèŠ‚æ¤ç‰©çš„ç”Ÿé•¿ã€å‘è‚²åŠé€†å¢ƒå“åº”ã€‚ä¾‹å¦‚ç³»ç»Ÿç´ ï¼ˆSyst...">

    <title>chapt 11.10 å°è‚½ - D.RAY</title>

    <!-- Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Outfit:wght@300;400;500;600;700&family=JetBrains+Mono:wght@400;500&display=swap"
        rel="stylesheet">

    <!-- Highlight.js -->
    <link rel="stylesheet"
        href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/styles/atom-one-dark.min.css">
    <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/highlight.min.js"></script>

    <!-- KaTeX -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js"></script>

    <!-- Marked.js for Markdown parsing -->
    <script src="https://cdn.jsdelivr.net/npm/marked/marked.min.js"></script>

    <!-- Mermaid.js for diagrams and flowcharts -->
    <script type="module">
        import mermaid from 'https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.esm.min.mjs';
        mermaid.initialize({
            startOnLoad: false,
            theme: 'dark',
            themeVariables: {
                primaryColor: '#8b5cf6',
                primaryTextColor: '#fff',
                primaryBorderColor: '#7c3aed',
                lineColor: '#a78bfa',
                secondaryColor: '#6d28d9',
                tertiaryColor: '#5b21b6'
            }
        });
        window.mermaid = mermaid;
    </script>

    <!-- Custom Styles -->
    <link rel="stylesheet" href="../../style.css">
    <link rel="icon" href="../../ico/favicon.ico" type="image/x-icon">

    <style>
        .article-page {
            max-width: 1150px;
            margin: 0 auto;
            padding: 2rem;
        }

        .article-header {
            margin-bottom: 3rem;
            padding-bottom: 2rem;
            border-bottom: 2px solid var(--border-color);
        }

        .article-title {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 1rem;
            line-height: 1.2;
        }

        .article-meta {
            display: flex;
            gap: 1rem;
            color: var(--text-secondary);
            font-size: 0.95rem;
        }

        .article-meta span {
            display: flex;
            align-items: center;
            gap: 0.3rem;
        }

        .back-link {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--accent-color);
            text-decoration: none;
            margin-bottom: 2rem;
            font-weight: 500;
            transition: transform 0.2s;
        }

        .back-link:hover {
            transform: translateX(-4px);
        }

        .article-content {
            font-size: 1.1rem;
            line-height: 1.8;
        }

        @media (max-width: 768px) {
            .article-page {
                padding: 1rem;
            }

            .article-title {
                font-size: 2rem;
            }
        }

        .article-footer {
            margin-top: 4rem;
            padding-top: 2rem;
            border-top: 1px solid var(--border-color);
            text-align: center;
            color: var(--text-secondary);
            font-size: 0.85rem;
        }

        .article-footer .disclaimer {
            font-size: 0.75rem;
            margin-top: 0.5rem;
            font-style: italic;
            opacity: 0.8;
        }
    </style>
    <meta name="build-hash" content="1fbe9c1092f62758d061771925469895">
</head>

<body>
    <div class="article-page">
        <a href="../../" class="back-link">
            <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none"
                stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <line x1="19" y1="12" x2="5" y2="12"></line>
                <polyline points="12 19 5 12 12 5"></polyline>
            </svg>
            è¿”å›ä¸»é¡µ
        </a>

        <div class="article-header">
            <h1 class="article-title">chapt 11.10 å°è‚½</h1>
            <div class="article-meta">
                <span>ğŸ“… 2026-01-14</span>
                <span>ğŸ“‚ æ¤ç‰©ç”Ÿç†å­¦/ååŠ</span>
            </div>
        </div>

        <article class="article-content markdown-body" id="article-content">
            <!-- Content will be rendered here -->
        </article>

        <!-- Store markdown content in a script tag -->
        <script type="text/markdown" id="markdown-source">
# chapt 11.10 å°è‚½

### ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š

**è‚½ç±»æ¿€ç´  (Peptide hormones, N):** ä¸€ç±»ç”± 5-60 ä¸ªæ°¨åŸºé…¸æ®‹åŸºç»„æˆçš„å°åˆ†å­ä¿¡å·å¤šè‚½ã€‚å®ƒä»¬ä½œä¸ºå—ä½“é…ä½“ï¼ˆLigandï¼‰ï¼Œåœ¨æä½æµ“åº¦ä¸‹ï¼ˆå¦‚é£æ‘©å°”çº§åˆ« femtomolarï¼‰å³å¯è°ƒèŠ‚æ¤ç‰©çš„ç”Ÿé•¿ã€å‘è‚²åŠé€†å¢ƒå“åº”ã€‚ä¾‹å¦‚ç³»ç»Ÿç´ ï¼ˆSysteminï¼‰å’Œæ¤ç‰©ç¡«è‚½ï¼ˆPSKï¼‰ã€‚

**ç³»ç»Ÿç´  (Systemin, N):** äººç±»å‘ç°çš„ç¬¬ä¸€ä¸ªæ¤ç‰©è‚½ç±»æ¿€ç´ ï¼Œç”± Gregory Pearce äº 1991 å¹´åˆ†ç¦»ã€‚å®ƒç”± 18 ä¸ªæ°¨åŸºé…¸ç»„æˆï¼Œæ¥æºäºå‰ä½“è›‹ç™½çš„åŠ å·¥ï¼Œå…·æœ‰é•¿è·ç¦»è¿è¾“èƒ½åŠ›ï¼Œä¸»è¦åœ¨æ¤ç‰©å—åˆ°æœºæ¢°æŸä¼¤æˆ–æ˜†è™«å–é£Ÿæ—¶è¯±å¯¼ç³»ç»Ÿæ€§é˜²å¾¡ååº”ï¼ˆå¦‚è›‹ç™½é…¶æŠ‘åˆ¶å‰‚çš„ç§¯ç´¯ï¼‰ã€‚

**ç¿»è¯‘åä¿®é¥° (Post-translational modifications, PTMs):** è‚½ç±»æ¿€ç´ å‰ä½“åœ¨ç¿»è¯‘åå‘ç”Ÿçš„åŒ–å­¦ä¿®é¥°è¿‡ç¨‹ï¼Œè¿™å¯¹äºèµ‹äºˆè‚½æ®µç”Ÿç‰©æ´»æ€§åŠç¨³å®šæ€§è‡³å…³é‡è¦ã€‚å¸¸è§çš„ä¿®é¥°åŒ…æ‹¬ï¼šè„¯æ°¨é…¸çš„**ç¾ŸåŸºåŒ–**ï¼ˆHydroxylationï¼‰ã€é…ªæ°¨é…¸çš„**ç¡«é…¸åŒ–**ï¼ˆSulfation, ç”± TPST é…¶å‚¬åŒ–ï¼‰ä»¥åŠåŠèƒ±æ°¨é…¸ä¹‹é—´å½¢æˆ**äºŒç¡«é”®**ï¼ˆDisulfide bridgesï¼‰ä»¥ç»´æŒç»“æ„ã€‚

**å‡¯æ°å¸¦ (Casparian strip, N):** æ ¹éƒ¨å†…çš®å±‚ç»†èƒå£çš„ç‰¹åŒ–ç»“æ„ï¼Œé˜»æ–­æ°´åˆ†å’Œç¦»å­çš„è‡ªç”±æ‰©æ•£ã€‚

---

### äºŒã€ æ¤ç‰©ç”Ÿç†å­¦é‡ç‚¹å†…å®¹å½’çº³

**1. è‚½ç±»æ¿€ç´ çš„ç‰¹å¾ä¸åˆ†ç±»**
*   **åŸºæœ¬ç‰¹å¾ï¼š** å°åˆ†å­ï¼ˆ5-60 aaï¼‰ã€ä½æµ“åº¦é«˜æ´»æ€§ã€éœ€è¦è†œå—ä½“ã€å¯è¿›è¡Œé•¿è·ç¦»æˆ–çŸ­è·ç¦»è¿è¾“ã€‚

**2. ç§»åŠ¨æ€§ä¸æ„ŸçŸ¥ (Mobility and Perception)**
*   **ç§»åŠ¨æœºåˆ¶ï¼š**
    *   **çŸ­è·ç¦»ï¼š** è´¨å¤–ä½“æ‰©æ•£ï¼ˆApoplastic diffusionï¼‰ï¼Œå¦‚æ ¹å°–çš„ CLE40ã€‚
    *   **é•¿è·ç¦»ï¼š** é€šè¿‡æœ¨è´¨éƒ¨ï¼ˆXylemï¼‰æˆ–éŸ§çš®éƒ¨ï¼ˆPhloemï¼‰è¿è¾“ã€‚ä¾‹å¦‚ï¼ŒCLE41 åœ¨ç»´ç®¡æŸä¸­ç§»åŠ¨ï¼›è±†ç§‘æ¤ç‰©ä¸­æ ¹éƒ¨äº§ç”Ÿçš„ CLE ä¿¡å·é€šè¿‡æœ¨è´¨éƒ¨å‘ä¸Šä¼ é€’æ°®ç´ çŠ¶æ€ï¼Œå¶ç‰‡äº§ç”Ÿçš„ä¿¡å·é€šè¿‡éŸ§çš®éƒ¨å‘ä¸‹è°ƒèŠ‚æ ¹ç˜¤æ•°é‡ã€‚

**3. ç”Ÿç†åŠŸèƒ½ (Physiological Roles)**
è‚½ç±»æ¿€ç´ è°ƒæ§æ¤ç‰©ä¸€ç”Ÿçš„å‘è‚²è¿‡ç¨‹ï¼š
*   **æ ¹ç³»å‘è‚²ï¼š** ä¾§æ ¹å‘ç”Ÿã€åˆ†ç”Ÿç»„ç»‡ç»´æŒ (RGFs)ã€æ ¹æ¯›ç”Ÿé•¿ã€å‡¯æ°å¸¦å½¢æˆ (CIFs)ã€‚
*   **ç”Ÿæ®–å‘è‚²ï¼š** èŠ±ç²‰ç®¡å¯¼å‘ (LUREs)ã€èŠ±ç²‰ç®¡ç ´è£‚é‡Šæ”¾ç²¾å­ (ES peptides)ã€èŠ±å™¨å®˜è„±è½ (IDA)ã€è‡ªäº¤ä¸äº²å’Œæ€§ã€‚
*   **é€†å¢ƒä¸å…±ç”Ÿï¼š** å…ç–«ååº”ã€æ ¹ç˜¤å›ºæ°®å…±ç”Ÿ (CLEs)ã€æ°”å­”è°ƒæ§ã€‚
*   **ç»´ç®¡æŸå‘è‚²ï¼š** è°ƒèŠ‚æœ¨è´¨éƒ¨å’ŒéŸ§çš®éƒ¨çš„åˆ†åŒ– (TDIF/CLE41)ã€‚

---

### ä¸‰ã€ é‡ç‚¹å®éªŒä¸ç ”ç©¶æ¦‚è¿°


**3. å‡¯æ°å¸¦å®Œæ•´æ€§å®éªŒ (CIF peptides)**
*   **å¯¹æ¯”ï¼š** é‡ç”Ÿå‹ (WT) vs *cif1 cif2* åŒçªå˜ä½“ã€‚
*   **ç°è±¡ï¼š** ä½¿ç”¨ *CASP1-GFP* æ ‡è®°è§‚å¯Ÿï¼ŒWT çš„å‡¯æ°å¸¦æ˜¯è¿ç»­çš„ï¼Œè€ŒåŒçªå˜ä½“çš„å‡¯æ°å¸¦å‘ˆç°**æ–­ç»­çŠ¶ (Discontinuous)**ã€‚åŒçªå˜ä½“å¯¹è¿‡é‡é“æ•æ„Ÿï¼Œç”Ÿé•¿å—é˜»ã€‚
*   **è¡¥æ•‘ï¼š** å¤–æºæ–½åŠ  CIF è‚½å¯ä»¥æ¢å¤çªå˜ä½“çš„å‡¯æ°å¸¦ç¼ºé™·ã€‚
*   **ç»“è®ºï¼š** è¯æ˜ CIF è‚½æ˜¯å‡¯æ°å¸¦æ‰©æ•£å±éšœå½¢æˆçš„å¿…éœ€ä¿¡å·å› å­ã€‚

**4. èŠ±å™¨å®˜è„±è½æœºåˆ¶ (Floral Organ Abscission)**
*   **æ¨¡å‹ï¼š** æ‹Ÿå—èŠ¥èŠ±ç“£è„±è½ã€‚
*   **å®éªŒï¼š** *ida* çªå˜ä½“å’Œå—ä½“çªå˜ä½“ *hae hsl2* å‡è¡¨ç°ä¸ºèŠ±ç“£æ— æ³•æ­£å¸¸è„±è½ã€‚
*   **æœºåˆ¶ï¼š** IDA è‚½ç»“åˆ HAE/HSL2 å—ä½“ï¼Œæ¿€æ´» MKK4/5 å’Œ MPK3/6ï¼Œè¿›è€Œè§£é™¤é˜»éè›‹ç™½ BP çš„æŠ‘åˆ¶ï¼Œä¿ƒè¿›ç»†èƒå£é™è§£é…¶çš„è¡¨è¾¾ï¼Œå¯¼è‡´ç¦»å±‚ç»†èƒåˆ†ç¦»ã€‚

---

### å››ã€ é—®é¢˜å›ç­” (Q&A)

**Q1: What are the challenges in predicting and identifying plant peptide hormones? (é¢„æµ‹å’Œé‰´å®šæ¤ç‰©è‚½ç±»æ¿€ç´ é¢ä¸´å“ªäº›æŒ‘æˆ˜ï¼Ÿ)**
**A:**
1.  **åŸºå› æ³¨é‡Šåå·®ï¼š** è‚½ç±»æ¿€ç´ åŸºå› é€šå¸¸å¾ˆå°ï¼ˆShort ORFsï¼‰ï¼Œå¸¸è¢«åŸºå› ç»„æ³¨é‡Šç®—æ³•å¿½ç•¥æˆ–é”™è¯¯è¿‡æ»¤ã€‚
2.  **åºåˆ—ä¿å®ˆæ€§ä½ï¼š** é™¤äº†å…³é”®æ®‹åŸºï¼ˆå¦‚åŠèƒ±æ°¨é…¸ï¼‰å¤–ï¼Œå®¶æ—æˆå‘˜é—´çš„åºåˆ—åŒæºæ€§å¾ˆä½ï¼Œéš¾ä»¥é€šè¿‡åºåˆ—æ¯”å¯¹å‘ç°æ–°æˆå‘˜ã€‚
3.  **åŠ å·¥è§„åˆ™ä¸æ˜ç¡®ï¼š** éš¾ä»¥å‡†ç¡®é¢„æµ‹å‰ä½“è›‹ç™½é…¶åˆ‡ä½ç‚¹ï¼Œå³ä¸çŸ¥é“å“ªä¸€æ®µæ˜¯æœ€ç»ˆçš„ç”Ÿç‰©æ´»æ€§è‚½ã€‚
4.  **ä¿®é¥°å¤æ‚ï¼š** æ´»æ€§å¾€å¾€ä¾èµ–äºç¿»è¯‘åä¿®é¥°ï¼ˆå¦‚ç£ºé…¸åŒ–ã€ç¾ŸåŸºåŒ–ï¼‰ï¼Œä»…å‡­åŸºå› åºåˆ—æ— æ³•é¢„æµ‹æœ€ç»ˆäº§ç‰©ç»“æ„ã€‚

**Q2: How do peptide hormones achieve specificity in signaling? (è‚½ç±»æ¿€ç´ å¦‚ä½•å®ç°ä¿¡å·è½¬å¯¼çš„ç‰¹å¼‚æ€§ï¼Ÿ)**
**A:**
ä¸»è¦é€šè¿‡**å—ä½“-å…±å—ä½“å¤åˆä½“**çš„ç‰¹å¼‚æ€§é…å¯¹æ¥å®ç°ã€‚è™½ç„¶å…±å—ä½“ï¼ˆå¦‚ SERK1/BAK1ï¼‰é€šå¸¸æ˜¯å…±äº«çš„ï¼ˆæ—¢å‚ä¸æ²¹èœç´ å†…é…¯ä¿¡å·ï¼Œä¹Ÿå‚ä¸ IDAã€RGF ç­‰ä¿¡å·ï¼‰ï¼Œä½†**ä¸»å—ä½“**ï¼ˆLigand-binding receptorï¼Œå¦‚ HAE, BRI1, RGIï¼‰å…·æœ‰é«˜åº¦çš„é…ä½“ç»“åˆç‰¹å¼‚æ€§ã€‚é…ä½“è¯±å¯¼ç‰¹å®šçš„å—ä½“-å…±å—ä½“äºŒèšåŒ–ï¼Œä»è€Œæ¿€æ´»ç‰¹å®šçš„ä¸‹æ¸¸é€šè·¯ã€‚

        </script>

        <footer class="article-footer">
            <p>&copy; 2025 Yukari502. All rights reserved.</p>
            <p class="disclaimer">Disclaimer: Portions of this content may be generated by AI. Please exercise
                discretion and verify information independently.</p>
        </footer>
    </div>

    <script src="../../script.js"></script>
</body>

</html>